68Ga-NeoBOMB1
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for 68Ga-NeoBOMB1, covering 2019-07-19 to 2020-10-23. Get the full timeline:
Most recent: Clinical Trial Update: [68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR) [Phase 2]